The key indices, Sensex and Nifty 50, ended lower on 5 May, driven by profit-taking. Mid- and small-cap stocks showed gains.

Prabhudas Lilladher is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated May 06, 2026.

The UDF will make a comeback in the state after 2016; however, the coalition's chief ministerial candidate has not been ...

The market may attempt to move upward as long as it holds the 20-day EMA, but the sustainability of the trend is key. Below ...

One of the world's largest carmakers is looking to China for some of its next-gen global cars. Volkswagen boss Oliver Blume said the company could export some of its currently China-only vehicles, ...

Tata Technologies shares shot up as much as 9% in early trade on Tuesday after the company announced its Q4 FY26 results. The ...

Equitas Small Finance Bank said that it has reported highest quarterly PAT of ₹213 crore in Q4FY26, registering a growth of ...

Chandigarh: Even as the Chandigarh administration pursues an ambitious reform agenda, a few long-pending demands — allowing ...

A couple weeks ago, a one-time check for $90 from the Social Security Administration showed up in my checking account. I wasn’t totally sure what that was all about, but I had a pretty good idea.

Experts think certain non-routine tests are worth asking your doctor about, since the results could point to health-saving ...

It is important to note that the Election Commission of India (ECI) has prohibited the release of any exit poll findings ...

Most companies want to understand how visitors interact with their websites. That insight supports better user experiences, improved conversion ...